Fig. 4

Relationship between SLC7A11 or NRF2 nuclear expression and clinical response to CRT. SLC7A11 (a) and nuclear NRF2 (b) treatment responses of ESCC patients. CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease